Top

Notice of Intent to Sole Source – Bio-Rad Laboratories, Inc.

Active

26-007652Federal

Response Deadline07/28/2026, 08:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The National Institutes of Health Clinical Center’s Department of Laboratory Medicine intends to award a sole source fixed-price purchase order to Bio-Rad Laboratories, Inc. for the Bio-Rad CFX Opus 96 Real-Time PCR System and associated reagents, to be delivered to Bethesda, Maryland. This procurement falls under simplified acquisition procedures as defined in FAR Part 13, allowing for non-competitive award because Bio-Rad is the only source reasonably available to fulfill the specific technical requirements necessary for ongoing research funded by the 2026 Research Award for Staff Clinicians. The equipment will be used to process patient samples in alignment with an approved research plan requiring institutional affiliation and technical continuity, justifying the absence of competitive bidding. The transaction is classified under Product Service Code 6515 and NAICS Code 339112, and the funding source is explicitly tied to internal NIH program funding. Although this is a notice of intent and not a formal solicitation, the government is inviting industry input prior to finalizing the award, with all comments due by July 29, 2026, directed to Kristin Nagashima at the NIH Office of Purchasing and Contracts. No formal quotations will be requested, and the decision to proceed without competition rests solely with the contracting officer under the provisions of FAR 13.106-1(b)(1), which permits sole source awards below the simplified acquisition threshold when unique circumstances limit the availability of alternative suppliers. The purchase will be executed under contract number 26-007652, and the performance location is confirmed as the NIH Clinical Center in Bethesda, Maryland.

General Info

NIH to award Bio-Rad sole source contract for PCR system and reagents in Bethesda for clinical research.

Agency

Department Of Health And Human Services → National Institutes Of Health - CcView Agency

NAICS

339112 - Surgical and Medical Instrument ManufacturingView NAICS

Place of Performance

MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 22

special-notice

Response DeadlineJul 28

Submission deadline

Response Deadline

07/28/2026, 08:00:00 PM UTCin 4 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health - Cc

View Agency Profile

Office AddressBETHESDA, MD, 20892, USA

Contacts

Kristin Nagashima

contact@example.gov

Full Description

The purpose of this procurement is to secure the instrument and reagents for the Bio-Rad CFX Opus 96 Real-Time PCR System to be used at the National Institutes of Health (NIH) Clinical Center (CC) Department of Laboratory Medicine (DLM)

• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

• Place of Performance: Bethesda, MD 20892 USA

POTS: 26-007652

Description:

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Bio-Rad Laboratories, Inc., located at 1000 Alfred Nobel Dr., Hercules, CA, 94547 on a firm fixed price sole source award basis to provide the required instrument and reagents to the National Institutes of Health DLM.

Funding for the research to be completed with the patient samples obtained through this contract is from the 2026 Research Award for Staff Clinicians (RASCL) Award to the NIH program. For the initial studies, a local PH center of excellence is required that has an institution affiliation with the IC. Thus, in order to maintain the integrity of the research plan and adhere to the proposed work that received funding, competition will be limited for this project.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 29, 2026 at 4pm EST.